Chargement en cours...
Glatiramer Acetate in the Treatment of Multiple Sclerosis: Emerging Concepts Regarding its Mechanism of Action
Glatiramer acetate is a synthetic, random copolymer widely used as a first-line agent for the treatment of relapsing-remitting multiple sclerosis (MS). While earlier studies primarily attributed its clinical effect to a shift in the cytokine secretion of CD4+ T helper (T(h)) cells, growing evidence...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3963480/ https://ncbi.nlm.nih.gov/pubmed/21476611 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2165/11588120-000000000-00000 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|